CAR T Cell Therapy: How It Works

At Memorial Sloan Kettering, we believe that immunotherapy is one of the most promising ways to treat, cure, and ultimately prevent cancer.
 
MSK scientists have led the way in using chimeric antigen receptor (CAR) T cell therapy to treat leukemia and certain solid tumors. In this approach, immune cells from a patient are removed from the body, armed with new proteins that recognize cancer, and given back to the patient in large numbers.